Therapeutical Approaches in Melasma

Dermatologic Clinics

Volumn 25, Issue 3, 2007, Pages 337-342

  Prignano, Francesca ^a   Ortonne, Jean Paul ^b   Buggiani, Gionata ^a   Lotti, Torello ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZELAIC ACID; BETAMETHASONE; CLOBETASOL PROPIONATE; DERMATOLOGICAL AGENT; DEXAMETHASONE; FLUOCINOLONE ACETONIDE; GLYCOLIC ACID; HYDROCORTISONE; HYDROQUINONE; ISOPROYLCATECHOL; KOJIC ACID; MONOBENZONE; N ACETYL 4 S CYSTEAMINYLPHENOL; PIDOBENZONE; RESORCINOL; RETINOIC ACID; SALICYLIC ACID; STEROID; SUNSCREEN; TRICHLOROACETIC ACID; UNCLASSIFIED DRUG;

ACNE; BURNING SENSATION; CHLOASMA; CONTACT ALLERGY; CONTACT DERMATITIS; CRYOSURGERY; DEPIGMENTATION; DERMATITIS; DESQUAMATION; DIFFERENTIAL DIAGNOSIS; DRUG HYPERSENSITIVITY; DRY SKIN; ERYTHEMA; HUMAN; HYPERPIGMENTATION; HYPERTROPHIC SCAR; KERATINOCYTE; LICHEN PLANUS; MELANOCYTE; MELANOCYTOTOXICITY; MELANOSIS; MONOTHERAPY; NAIL COLOR DEFECT; NAIL DISCOLORATION; OCHRONOSIS; PHOTOSENSITIZATION; POSTINFLAMMATORY HYPERMELANOSIS; PRIORITY JOURNAL; PRURITUS; REVIEW; SIDE EFFECT; SKIN ABRASION; SKIN ALLERGY; SKIN ATROPHY; SKIN IRRITATION; SKIN NECROSIS; SKIN PIGMENTATION; SKIN TOXICITY; SUN EXPOSURE; TELANGIECTASIA; TREATMENT INDICATION; TREATMENT OUTCOME; ULTRAVIOLET RADIATION;

CHEMEXFOLIATION; COSMETICS; DERMATOLOGIC AGENTS; DICARBOXYLIC ACIDS; DRUG COMBINATIONS; HUMANS; HYDROQUINONES; HYDROXYBENZOIC ACIDS; LASERS; MELANOSIS; PYRONES; TRETINOIN;

EID: 34447643375     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2007.04.006     Document Type: Review

References (30)

1. Grimes P.E. Melasma: etiologic and therapeutic considerations. Arch Dermatol Res 131 (1995) 1453-1457
2. Sanchez N.P., Pathak M.Z., Fitzpatrick T.B., et al. Melasma. J Am Acad Dermatol 4 (1981) 698-710
3. Victor F.C., Gelberg J., and Rao B. Melasma: a review. J Cutan Med Surg 8 (2004) 97-102
4. Johnston G.A., Sviland L., and McLelland J. Melasma of the arms associated with hormone replacement therapy. Br J Dermatol 139 (1988) 932
5. Gilchrest B.A., Fitzpatrick T.B., Anderson R.R., et al. Localization of melanin pigmentation with Wood's lamp. Br J Dermatol 96 (1977) 245-248
6. Nakayama H., Harada R., and Toda M. Pigmented cosmetic dermatitis. Int J Dermatol 15 (1976) 673-675
7. Serrano G., Pujol C., and Cuadra J. Riehl's melanosis: pigmented contact dermatitis caused by fragrances. J Am Acad Dermatol 21 (1989) 1057-1060
8. Draelos Z.K. Cosmetic camouflaging techniques. Cutis 52 (1993) 362-364
9. Gupta A.K., Gover M.D., Nouri K., et al. The treatment of melasma: a review of clinical trials. J Am Acad Dermatol 55 (2006) 1048-1065
10. Palumbo A., D'Ischia M., Misuraca G., et al. Mechanism of inhibition of melanogenesis by hydroquinone. Biochim Biophys Acta 90 (1991) 1073-1085
11. Rendon M., Berneburg M., Arellano I., et al. Treatment of melasma. J Am Acad Dermatol 54 (2006) S2272-S2281
12. Ennes S.B.P., Paschoalick R.C., De Avelar M., et al. A double-blind, comparative, placebo-controlled study of the efficacy and tolerability of hydroquinone as a depigmenting agent in melasma. J Dermatol Treat 11 (2001) 173-179
13. Barrientos N., Ortiz-Frutos J., Gomez E., et al. Allergic contact dermatitis from a bleaching cream. Am J Contact Dermat 12 (2001) 33-34
14. Colomb D. Depigmentation en confettis après application de leucodinine B sur un cloasma. Ann Dermatol Venereol 109 (1982) 899-900 [in French]
15. Bleehen S.S. The treatment of hypermelanosis with 4-isopropylcatechol. Br J Dermatol 94 (1976) 687-694
16. Jimbow K. N-acetyl-4S-cysteaminylphenol as a new type of depigmenting agent for the melanoderma of patients with melasma. Arch Dermatol 127 (1991) 1528-1534
17. Romero C., Aberdam E., Larnier C., et al. Retinoic acid as modulator of UVB-induced melanocyte differentiation. J Cell Sci 107 (1994) 1095-1103
18. Torok H.M. A comprehensive review of the long-term and short-term treatment of melasma with a triple combination cream. Am J Clin Dermatol 7 (2006) 223-230
19. Fitton A., and Goal K.L. Azelaic acid: a review of its pharmacological of properties and therapeutic efficacy in acne and hyperpigmentary skin disorders. Drugs 41 (1991) 780-798
20. Verallo-Rowell V.M., Verallo V., Graupe K., et al. Double-blind comparison of azelaic acid and hydroquinone in the treatment of melasma. Acta Derm Venereol Suppl (Stockh) 143 (1989) 58-61
21. Ballina L.M., and Graupe K. The treatment of melasma with 20% azelaic acid versus 4% hydroquinone cream. Int J Dermatol 30 (1991) 893-895
22. Cabanes J., Chazarra S., and Garcia-Carmona F. Kojic acid, a cosmetic skin whitening agent, is a slow-binding inhibitor of cathecolase activity of tyrosinase. J Pharm Pharmacol 46 (1994) 982-985
23. Nakagawa M., Kawai K., and Kawai K. Contact allergy to kojic acid in skin care products. Contact dermatitis 32 (1995) 9-13
24. Zanieri F, Assad Bani G, Campolmi P, et al. Melasma: successful treatment with pidobenzone 4% (K5 Lipogel). Dermatol Ther, in press.
25. Kligman A.M., and Willis I. A new formula for depigmenting human skin. Arch Dermatol 111 (1975) 40-48
26. Kang W.H., Chun S.C., and Lee S. Intermittent therapy for melasma in Asian patients with combined topical agents (retinoic acid, hydroquinone and hydrocortisone): clinical and histological studies. J Dermatol 25 (1998) 587-596
27. Kameyama K., Sakai C., Kondoch S., et al. Inhibitory effect of magnesium L-ascorbiyl-2-phosphate (VC-PMG) on melanogenesis in vitro and in vivo. J Am Acad Dermatol 34 (1996) 29-33
28. Iorizzo M., Tosti A., and De Padova M.P. Melasma. In: Tosti A., Grimes PE., and De Padova M.P. (Eds). Color atlas of chemical peels (2006), Springer, Berlin 149-158
29. nd edition (2003), Springer, Berlin p. 121-7
30. Angsuwarangsee S., and Polnikorn N. Combined ultrapulse CO2 laser and Q-switched alexandrite laser compared with Q-switched alexandrite laser alone for refractory melasma: split-faced design. Dermatol Surg 29 (2003) 59-64